Dao Wen Wang: Clinical Trials

3 trials sponsored by Dao Wen Wang, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed. .

Follow Dao Wen Wang: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Observational Cohort of COVID-19 Patients in Hubei Province
No intervention - 2019 Novel Coronavirus Disease
CompletedDao Wen Wang680002020-02-012024-03-07
Immunomodulatory Therapy & VSA
glucocorticosteroids and/or intravenous immunoglobulin - Vasospastic Angina
CompletedDao Wen Wang712018-10-012024-11-20
The Effects of Glimepiride in Patients With Type 2 Diabetes and Chronic Heart Failure
Glimepiride - Chronic Heart Failure, Type 2 Diabetes
CompletedDao Wen Wang10182017-06-012022-11-16

Conditions studied

Angina Pectoris, Variant (1)  ·  COVID-19 (1)  ·  Diabetes Mellitus, Type 2 (1)

Interventions

glimepiride (1)

Countries

China (3)

Results publications

PMID 36573717, PMID 37566218, PMID 38467760